Journal articleEur J Cancer2021

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.

DOI 10.1016/j.ejca.2021.03.040 ↗ OpenAlex, retrieved 5 November 2026

Journal: Eur J Cancer
Published: 2 May 2021
Citations: 47
Type: Article
License: cc by

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try